Eric Wahlberg Selected Research

3-acetylpyridine adenine dinucleotide (APAD)

6/2022	Presence of asymptomatic Peripheral Arterial Disease in combination with common risk factors elevates the cardiovascular risk Substantially.
10/2019	Cardiovascular long-term outcome and prophylactic treatment patterns in peripheral arterial disease in a population-based cohort.
1/2018	Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome.
2/2009	Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Wahlberg Research Topics

Disease

7	Ischemia 08/2007 - 03/2002
3	Peripheral Arterial Disease 06/2022 - 08/2007
3	Intermittent Claudication 10/2019 - 02/2009
3	Chronic Limb-Threatening Ischemia 02/2009 - 03/2004
2	Inflammation (Inflammations) 01/2003 - 12/2002
1	Diabetes Mellitus 06/2022
1	Hypertension (High Blood Pressure) 06/2022
1	Neoplasms (Cancer) 07/2013
1	Atherosclerotic Plaque (Atheroma) 07/2013
1	Hemorrhage 07/2010
1	Vascular Remodeling 09/2007
1	Disease Progression 01/2003
1	Myocardial Infarction 01/2003
1	Stroke (Strokes) 01/2003
1	Hypoxia (Hypoxemia) 12/2002
1	Proteinuria 07/2002
1	Azotemia 07/2002
1	Hypotension (Low Blood Pressure) 07/2002
1	Acute Kidney Injury (Acute Renal Failure) 07/2002

Drug/Important Bio-Agent (IBA)

4	3-acetylpyridine adenine dinucleotide (APAD)IBA 06/2022 - 02/2009
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2004 - 12/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2013 - 12/2002
2	CytokinesIBA 09/2007 - 01/2003
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 03/2004 - 05/2003
1	Bevacizumab (Avastin)FDA Link 07/2013
1	Apolipoproteins E (ApoE)IBA 07/2013
1	ApolipoproteinsIBA 07/2013
1	LipidsIBA 07/2013
1	LDL Receptors (LDL Receptor)IBA 07/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2009
1	Cardiovascular AgentsIBA 02/2009
1	interleukin 20 (IL-20)IBA 09/2007
1	Oral ContraceptivesIBA 07/2004
1	Becaplermin (PDGF-BB)FDA Link 05/2003
1	Peptide Hydrolases (Proteases)FDA Link 01/2003
1	NitrogenIBA 07/2002
1	CreatinineIBA 07/2002
1	Urea (Carbamide)FDA LinkGeneric 07/2002

Therapy/Procedure

3	Therapeutics 07/2013 - 01/2003
2	Surgical Amputation (Amputations) 05/2008 - 03/2002
1	Operative Surgical Procedures 07/2010
1	Vascular Surgical Procedures 08/2007
1	Endovascular Procedures 07/2004
1	Drug Therapy (Chemotherapy) 01/2003
1	Aftercare (After-Treatment) 03/2002